Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
8.94
Nov 17 • 3:00 PM ET Dollar change-0.06 Percentage change(-0.72%)
Index
-
Market Cap
99.08M
Enterprise Value
143.01M
Income
-27.08M
Sales
105.21M
Book/sh
0.78
Cash/sh
2.57
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
334
IPO
Oct 28, 2020
P/E
-
Forward P/E
-
PEG
-
P/S
0.94
P/B
11.39
P/C
3.48
P/FCF
-
EV/EBITDA
-
EV/Sales
1.36
Quick Ratio
2.87
Current Ratio
2.96
Debt/Eq
8.35
LT Debt/Eq
8.09
Option/Short
No / Yes
EPS (ttm)
-2.76
EPS next Y
-1.99
EPS next Q
-0.69
EPS this Y
36.74%
EPS next Y
32.68%
EPS next 5Y
39.58%
EPS past 3/5Y
46.84% 27.68%
Sales past 3/5Y
32.31% 14.20%
EPS Y/Y TTM
48.56%
Sales Y/Y TTM
31.23%
EPS Q/Q
35.16%
Sales Q/Q
10.44%
Insider Own
55.58%
Insider Trans
2.37%
Inst Own
41.12%
Inst Trans
3.50%
ROA
-29.65%
ROE
-778.89%
ROIC
-34.31%
Gross Margin
81.16%
Oper. Margin
-18.68%
Profit Margin
-25.74%
SMA20
-48.03%
SMA50
-61.48%
SMA200
-52.66%
Trades
Shs Outstand
11.05M
Shs Float
4.93M
52W High
31.97 -72.05%
52W Low
5.26 69.87%
Volatility
13.51% 14.13%
ATR (14)
2.13
RSI (14)
22.95
Beta
0.79
Rel Volume
0.61
Avg Volume
165.41K
Volume
86,710
Perf Week
-10.83%
Perf Month
-61.82%
Perf Quarter
-65.02%
Perf Half Y
-35.90%
Perf YTD
31.40%
Perf Year
12.82%
Perf 3Y
-68.76%
Perf 5Y
-93.16%
Perf 10Y
-
Prev Close
9.00
Price
8.94
Change %
-0.72%
Consensus
Strong Buy
Avg. Price Target
$32.17
Implied Upside
+260.0%
Analysts10incl. previous ratings
Rating Distribution9 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jun 25, 2026Initiated
RRoth Capital
Buy$32+258.1%
Jun 15, 2026Initiated
HH.C. Wainwright
Buy$26+191.0%
Feb 27, 2026Upgrade
WWilliam Blair
Mkt Perform → Outperform
May 14, 2025Downgrade
WWilliam Blair
Outperform → Mkt Perform
Sep 16, 2024Initiated
BNS logoBScotiabank
Sector Outperform
Jul 26, 2024Initiated
CCraig Hallum
Buy$3-66.4%
May 13, 2024Initiated
TD logoTTD Cowen
Buy$2.80-68.7%
May 03, 2024Initiated
LLake Street
Buy$3-66.4%
Nov 17, 2021Downgrade
MS logoMMorgan Stanley
Overweight → Equal-Weight$21 → $11+23.1%
Nov 23, 2020Initiated
WWilliam Blair
Outperform
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHULER JACK WEmeritus DirectorNov 10 '26Buy10.02100,0001,001,990655,810Nov 12 09:29 AM
SCHULER JACK WEmeritus DirectorAug 12 '26Buy24.4715,000366,992555,810Aug 13 05:22 PM
SCHULER JACK WEmeritus DirectorAug 10 '26Buy24.2513,900337,029527,110Aug 12 05:55 PM
SCHULER JACK WEmeritus DirectorAug 11 '26Buy24.0113,700328,911540,810Aug 12 05:55 PM
Pestano Gary AnthonyChief Development OfficerFeb 23 '26Sale12.785567,10310,359Feb 23 08:22 PM
O'Kane KieranChief Commercial OfficerFeb 23 '26Sale12.785356,8359,819Feb 23 08:22 PM
Cowie Robin HarperCFO, Sec'y & TreasurerFeb 23 '26Sale12.785356,83516,231Feb 23 08:22 PM
Vazquez ChrisChief Accounting OfficerFeb 23 '26Sale12.782112,6961,586Feb 23 08:22 PM
Hutton ScottPresident & CEOFeb 23 '26Sale12.781,49019,03648,767Feb 23 08:22 PM
Hutton ScottOfficerFeb 23 '26Proposed Sale12.771,49019,027Feb 23 08:22 PM
O'Kane KieranChief Commercial OfficerFeb 10 '26Sale10.085845,8898,885Feb 11 06:03 PM
Vazquez ChrisChief Accounting OfficerFeb 10 '26Sale10.081011,0181,234Feb 11 06:03 PM
Hutton ScottPresident & CEOFeb 10 '26Sale10.083,55935,88945,413Feb 11 06:03 PM
Cowie Robin HarperCFO, Sec'y & TreasurerFeb 10 '26Sale10.089419,48915,297Feb 11 06:03 PM
Pestano Gary AnthonyChief Development OfficerFeb 10 '26Sale10.085405,4459,387Feb 11 06:03 PM
SCHULER JACK WEmeritus DirectorJan 23 '26Buy11.8180,000944,6721,543,210Jan 27 09:29 AM
SCHULER JACK WEmeritus DirectorJan 26 '26Buy11.8020,000236,0641,563,210Jan 27 09:29 AM
SCHULER JACK WEmeritus DirectorJan 22 '26Buy10.9682,465903,5611,463,210Jan 26 09:28 AM
Vazquez ChrisChief Accounting OfficerJan 16 '26Sale8.15836761,072Jan 20 04:22 PM
Pestano Gary AnthonyChief Development OfficerJan 16 '26Sale8.152982,4288,446Jan 20 04:21 PM
O'Kane KieranChief Commercial OfficerJan 16 '26Sale8.152982,4287,869Jan 20 04:21 PM
Hutton ScottPresident & CEOJan 16 '26Sale8.159707,90538,974Jan 20 04:21 PM
Cowie Robin HarperCFO, Sec'y & TreasurerJan 16 '26Sale8.152982,42813,654Jan 20 04:21 PM
Biodesix, Inc. operates as a diagnostic solutions company. It engages in providing blood-based diagnostic tests and development services. The firm offers five diagnostic tests, including Nodify CDT, Nodify XL2, GeneStrat ddPCR, GeneStrat NGS, and VeriStrat. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.
PresidentMr. Scott Hutton
CFOMs. Robin Harper Cowie
Founder & CTODr. Heinrich Roder D.Phil
Chief Scientific OfficerDr. Gary Anthony Pestano Ph.D.
Vice President of Human ResourcesMs. Jessica Olbricht